Volume 3 Issue 9 - 2021
Need for Adherence to Healthy Behaviour in the Post - Covid-19 Immunisation Scenario
Sindhu Joseph1,3* and Jijo Pulickiyil Ulahannan2,3
1GPM Government College, Kannur University, Kerala, India
2Government College Kasaragod, Kannur University, Kerala, India
3Collective for Open Data Distribution - Keralam (CODD-K), Kerala, India
*Corresponding Author: Sindhu Joseph, GPM Government College, Kannur University, Kerala, India.
Received: November 12, 2021; Published: November 29, 2021


The COVID-19 pandemic has disrupted the balance of life and has affected millions of livelihoods with the closure of international borders, shutting down businesses and the loss of the near and dear. Vaccination has been accepted as the single efficient clinical intervention, and therefore countries are progressing with an increased rate of vaccination. However, infections among the vaccinated people have increasingly been reported with the onset of different variants of COVID-19, strong enough to penetrate the shield of vaccine protection [1-3].

Amidst the vaccination drive, governments around the globe have given importance to lockdowns and called for social behaviours to mitigate newer infections. However, previous studies noted that confirming the effect of vaccination and its strength are yet to be guaranteed drop-in conditions in a particular area as it might also be described by other factors, like lockdowns and behavioural changes such as social distancing and masking [4]. Further, the virus could open out from asymptomatic infection carriers, making it difficult to spot those infections, as was seen during the trial of Moderna’s vaccine. The research team saw a drop in the cases of asymptomatic infections by two-third among those who got the first dose of the double-dose vaccine, compared to those who took a placebo [4]. However, about a month apart, they could test people only twice, leaving chances for failure to notice the infections.


  1. Jennifer Kates., et al. “COVID-19 vaccine breakthrough cases: Data from the states” (2021).
  2. Centers for Disease Control and Prevention. COVID-19 Breakthrough Case Investigations and Reporting (2021).
  3. Haas EJ., et al. “Impact and effectiveness of mRNA BNT162b2 vaccine against SARS-CoV-2 infections and COVID-19 cases, hospitalisations, and deaths following a nationwide vaccination campaign in Israel: an observational study using national surveillance data”. Lancet10287 (2021): 1819-1829.
  4. Mallapaty S. “Can COVID vaccines stop transmission? Scientists race to find answers”. Nature (2021).
  5. Coetzee BJ and Kagee A. “Structural barriers to adhering to health behaviours in the context of the COVID-19 crisis: Considerations for low- and middle-income countries”. Global Public Health8 (2020): 1093-1102.
  6. World Health Organization. Statement for healthcare professionals: How COVID-19 vaccines are regulated for safety and effectiveness”. World Health Organization (2021).
  7. National Centre for Disease Control. National Guidelines for Infection Prevention and Control in Healthcare Facilities. Ministry of Health and Family Welfare, Government of India (2020).
  8. Ritchie H and Roser M. “Gender Ratio”. Our World in Data (2019).
  9. Cane J., et al. “Validation of the theoretical domains framework for use in behaviour change and implementation research”. Implementation Science 7 (2012): 37.
  10. Michie S., et al. “The Behaviour Change Wheel: A Guide to Designing Interventions”. Silverback Publishing (2014): 329.
  11. Waisel DB. “Vulnerable populations in healthcare”. Current Opinion in Anesthesiology 2 (2013): 186-192.
  12. Caprara G. “Mediterranean-Type Dietary Pattern and Physical Activity: The Winning Combination to Counteract the Rising Burden of Noncommunicable Diseases (NCDs)”. Nutrients2 (2021).
  13. Gyasi RM and Phillips DR. “Aging and the Rising Burden of Noncommunicable Diseases in Sub-Saharan Africa and other Low- and Middle-Income Countries: A Call for Holistic Action”. Gerontologist5 (2020): 806-811.
  14. “World Report on Ageing and Health”. World Health Organization (2015): 258.
  15. Marengoni A., et al. “Aging with multimorbidity: a systematic review of the literature”. Ageing Research Reviews4 (2011): 430-439.
  16. Cena H and Calder PC. “Defining a Healthy Diet: Evidence for The Role of Contemporary Dietary Patterns in Health and Disease”. Nutrients2 (2020).
  17. World Health Organization. Global Action Plan on Physical Activity 2018-2030: More Active People for a Healthier World”. World Health Organization (2019): 101.
  18. Chaput J-P., et al. “WHO guidelines on physical activity and sedentary behaviour for children and adolescents aged 5-17 years: summary of the evidence”. International Journal of Behavioral Nutrition and Physical Activity1 (2020): 141.
  19. Mikkelsen B., et al. “Life course approach to prevention and control of noncommunicable diseases”. British Medical Journal 364 (2019): l257.
Citation: Sindhu Joseph and Jijo Pulickiyil Ulahannan. “Need for Adherence to Healthy Behaviour in the Post - Covid-19 Immunisation Scenario”. EC Nursing and Healthcare 3.9 (2021): 43-46.

PubMed Indexed Article

EC Pharmacology and Toxicology
LC-UV-MS and MS/MS Characterize Glutathione Reactivity with Different Isomers (2,2' and 2,4' vs. 4,4') of Methylene Diphenyl-Diisocyanate.

PMID: 31143884 [PubMed]

PMCID: PMC6536005

EC Pharmacology and Toxicology
Alzheimer's Pathogenesis, Metal-Mediated Redox Stress, and Potential Nanotheranostics.

PMID: 31565701 [PubMed]

PMCID: PMC6764777

EC Neurology
Differences in Rate of Cognitive Decline and Caregiver Burden between Alzheimer's Disease and Vascular Dementia: a Retrospective Study.

PMID: 27747317 [PubMed]

PMCID: PMC5065347

EC Pharmacology and Toxicology
Will Blockchain Technology Transform Healthcare and Biomedical Sciences?

PMID: 31460519 [PubMed]

PMCID: PMC6711478

EC Pharmacology and Toxicology
Is it a Prime Time for AI-powered Virtual Drug Screening?

PMID: 30215059 [PubMed]

PMCID: PMC6133253

EC Psychology and Psychiatry
Analysis of Evidence for the Combination of Pro-dopamine Regulator (KB220PAM) and Naltrexone to Prevent Opioid Use Disorder Relapse.

PMID: 30417173 [PubMed]

PMCID: PMC6226033

EC Anaesthesia
Arrest Under Anesthesia - What was the Culprit? A Case Report.

PMID: 30264037 [PubMed]

PMCID: PMC6155992

EC Orthopaedics
Distraction Implantation. A New Technique in Total Joint Arthroplasty and Direct Skeletal Attachment.

PMID: 30198026 [PubMed]

PMCID: PMC6124505

EC Pulmonology and Respiratory Medicine
Prevalence and factors associated with self-reported chronic obstructive pulmonary disease among adults aged 40-79: the National Health and Nutrition Examination Survey (NHANES) 2007-2012.

PMID: 30294723 [PubMed]

PMCID: PMC6169793

EC Dental Science
Important Dental Fiber-Reinforced Composite Molding Compound Breakthroughs

PMID: 29285526 [PubMed]

PMCID: PMC5743211

EC Microbiology
Prevalence of Intestinal Parasites Among HIV Infected and HIV Uninfected Patients Treated at the 1o De Maio Health Centre in Maputo, Mozambique

PMID: 29911204 [PubMed]

PMCID: PMC5999047

EC Microbiology
Macrophages and the Viral Dissemination Super Highway

PMID: 26949751 [PubMed]

PMCID: PMC4774560

EC Microbiology
The Microbiome, Antibiotics, and Health of the Pediatric Population.

PMID: 27390782 [PubMed]

PMCID: PMC4933318

EC Microbiology
Reactive Oxygen Species in HIV Infection

PMID: 28580453 [PubMed]

PMCID: PMC5450819

EC Microbiology
A Review of the CD4 T Cell Contribution to Lung Infection, Inflammation and Repair with a Focus on Wheeze and Asthma in the Pediatric Population

PMID: 26280024 [PubMed]

PMCID: PMC4533840

EC Neurology
Identifying Key Symptoms Differentiating Myalgic Encephalomyelitis and Chronic Fatigue Syndrome from Multiple Sclerosis

PMID: 28066845 [PubMed]

PMCID: PMC5214344

EC Pharmacology and Toxicology
Paradigm Shift is the Normal State of Pharmacology

PMID: 28936490 [PubMed]

PMCID: PMC5604476

EC Neurology
Examining those Meeting IOM Criteria Versus IOM Plus Fibromyalgia

PMID: 28713879 [PubMed]

PMCID: PMC5510658

EC Neurology
Unilateral Frontosphenoid Craniosynostosis: Case Report and a Review of the Literature

PMID: 28133641 [PubMed]

PMCID: PMC5267489

EC Ophthalmology
OCT-Angiography for Non-Invasive Monitoring of Neuronal and Vascular Structure in Mouse Retina: Implication for Characterization of Retinal Neurovascular Coupling

PMID: 29333536 [PubMed]

PMCID: PMC5766278

EC Neurology
Longer Duration of Downslope Treadmill Walking Induces Depression of H-Reflexes Measured during Standing and Walking.

PMID: 31032493 [PubMed]

PMCID: PMC6483108

EC Microbiology
Onchocerciasis in Mozambique: An Unknown Condition for Health Professionals.

PMID: 30957099 [PubMed]

PMCID: PMC6448571

EC Nutrition
Food Insecurity among Households with and without Podoconiosis in East and West Gojjam, Ethiopia.

PMID: 30101228 [PubMed]

PMCID: PMC6086333

EC Ophthalmology
REVIEW. +2 to +3 D. Reading Glasses to Prevent Myopia.

PMID: 31080964 [PubMed]

PMCID: PMC6508883

EC Gynaecology
Biomechanical Mapping of the Female Pelvic Floor: Uterine Prolapse Versus Normal Conditions.

PMID: 31093608 [PubMed]

PMCID: PMC6513001

EC Dental Science
Fiber-Reinforced Composites: A Breakthrough in Practical Clinical Applications with Advanced Wear Resistance for Dental Materials.

PMID: 31552397 [PubMed]

PMCID: PMC6758937

EC Microbiology
Neurocysticercosis in Child Bearing Women: An Overlooked Condition in Mozambique and a Potentially Missed Diagnosis in Women Presenting with Eclampsia.

PMID: 31681909 [PubMed]

PMCID: PMC6824723

EC Microbiology
Molecular Detection of Leptospira spp. in Rodents Trapped in the Mozambique Island City, Nampula Province, Mozambique.

PMID: 31681910 [PubMed]

PMCID: PMC6824726

EC Neurology
Endoplasmic Reticulum-Mitochondrial Cross-Talk in Neurodegenerative and Eye Diseases.

PMID: 31528859 [PubMed]

PMCID: PMC6746603

EC Psychology and Psychiatry
Can Chronic Consumption of Caffeine by Increasing D2/D3 Receptors Offer Benefit to Carriers of the DRD2 A1 Allele in Cocaine Abuse?

PMID: 31276119 [PubMed]

PMCID: PMC6604646

EC Anaesthesia
Real Time Locating Systems and sustainability of Perioperative Efficiency of Anesthesiologists.

PMID: 31406965 [PubMed]

PMCID: PMC6690616

EC Pharmacology and Toxicology
A Pilot STEM Curriculum Designed to Teach High School Students Concepts in Biochemical Engineering and Pharmacology.

PMID: 31517314 [PubMed]

PMCID: PMC6741290

EC Pharmacology and Toxicology
Toxic Mechanisms Underlying Motor Activity Changes Induced by a Mixture of Lead, Arsenic and Manganese.

PMID: 31633124 [PubMed]

PMCID: PMC6800226

EC Neurology
Research Volunteers' Attitudes Toward Chronic Fatigue Syndrome and Myalgic Encephalomyelitis.

PMID: 29662969 [PubMed]

PMCID: PMC5898812

EC Pharmacology and Toxicology
Hyperbaric Oxygen Therapy for Alzheimer's Disease.

PMID: 30215058 [PubMed]

PMCID: PMC6133268

News and Events

September Issue Release

We always feel pleasure to share our updates with you all. Here, notifying you that we have successfully released the September issue of respective journals and the latest articles can be viewed on the current issue pages.

Submission Deadline for Upcoming Issue

ECronicon delightfully welcomes all the authors around the globe for effective collaboration with an article submission for the upcoming issue of respective journals. Submissions are accepted on/before October 06, 2022.

Certificate of Publication

ECronicon honors with a "Publication Certificate" to the corresponding author by including the names of co-authors as a token of appreciation for publishing the work with our respective journals.

Best Article of the Issue

Editors of respective journals will always be very much interested in electing one Best Article after each issue release. The authors of the selected article will be honored with a "Best Article of the Issue" certificate.

Certifying for Review

ECronicon certifies the Editors for their first review done towards the assigned article of the respective journals.

Latest Articles

The latest articles will be updated immediately on the articles in press page of the respective journals.